Concepedia

Raymond K. Tong

RK

Statistics

Publications

23

Citations

3.9K

H-Index

21

Active since

2007

Affiliations

Denali Therapeutics (United States)(Current)

Angiogenesis Foundation

University of Minnesota

PDL BioPharma (United States)

Research & Diagnostic Antibodies (United States)

Raymond K. Tong is an author at Denali Therapeutics (United States) specializing in pharmacy, pharmacology, and blood-brain barrier penetration.

ORCID

Publications per year

2007–2025

23

Publications

23

Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth

Qi Pan, Yvan H. Chanthery, Wei‐Ching Liang et al. · Cancer Cell · 2007 · 531 citations · Full text

, , +14

Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates

Yang Yu, Jasvinder K. Atwal, Yin Zhang et al. · Science Translational Medicine · 2014 · 369 citations

, , +17

Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys

Mihalis S. Kariolis, Robert C. Wells, Jennifer A. Getz et al. · Science Translational Medicine · 2020 · 355 citations

, , +17

Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis

Maresa Caunt, Judy Mak, Wei‐Ching Liang et al. · Cancer Cell · 2008 · 338 citations · Full text

, , +10

Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice

Megan Lo, Hok Seon Kim, Raymond K. Tong et al. · Journal of Biological Chemistry · 2017 · 330 citations · Full text

, , +16

1–5 of 23